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Abstract
Background: In Africa hypertension is common and stroke is increasing. Detection, treatment
and control of high blood pressure (BP) is limited. BP can be lowered by reducing salt intake. In
Africa salt is added to the food by the consumer, as processed food is rare. A population-wide
approach with programmes based on health education and promotion is thus possible.
Methods: We carried out a community-based cluster randomised trial of health promotion in
1,013 participants from 12 villages (628 women, 481 rural dwellers); mean age 55 years to reduce
salt intake and BP. Average BP was 125/74 mmHg and urinary sodium (UNa) 101 mmol/day. A
health promotion intervention was provided over 6 months to all villages. Assessments were made
at 3 and 6 months. Primary end-points were urinary sodium excretion and BP levels.
Results: There was a significant positive relationship between salt intake and both systolic (2.17
mmHg [95% CI 0.44 to 3.91] per 50 mmol of UNa per day, p < 0.001) and diastolic BP (1.10 mmHg
[0.08 to 1.94], p < 0.001) at baseline. At six months the intervention group showed a reduction in
systolic (2.54 mmHg [-1.45 to 6.54]) and diastolic (3.95 mmHg [0.78 to 7.11], p = 0.015) BP when
compared to control. There was no significant change in UNa. Smaller villages showed greater
reductions in UNa than larger villages (p = 0.042). Irrespective of randomisation, there was a
consistent and significant relationship between change in UNa and change in systolic BP, when
adjusted for confounders. A difference in 24-hour UNa of 50 mmol was associated with a lower
systolic BP of 2.12 mmHg (1.03 to 3.21) at 3 months and 1.34 mmHg (0.08 to 2.60) at 6 months
(both p < 0.001).
Conclusion: In West Africa the lower the salt intake, the lower the BP. It would appear that a
reduction in the average salt intake in the whole community may lead to a small but significant
reduction in population systolic BP.
Published: 24 January 2006
BMC Public Health 2006, 6:13 doi:10.1186/1471-2458-6-13
Received: 21 July 2005
Accepted: 24 January 2006
This article is available from: http://www.biomedcentral.com/1471-2458/6/13
© 2006 Cappuccio et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 11
(page number not for citation purposes)
BMC Public Health 2006, 6:13 http://www.biomedcentral.com/1471-2458/6/13Background
Non-communicable diseases are an important threat to
the health of adults in Africa [1]. Worldwide, stroke is sec-
ond only to ischaemic heart disease as a cause of death
(over 4 million in 1990), and most of these deaths are in
developing countries [2,3]. In sub-Saharan Africa, hyper-
tension is common [4-7] and its detection, prevention,
management and control should now be regarded as a pri-
ority [8]. It is estimated that if the 10–20 million people
believed to have hypertension in sub-Saharan Africa were
treated, about a quarter of a million deaths and twice as
many long-term disabilities would be prevented annually
[8]. Furthermore, in Africa, the reduction in population
attributable risk when blood pressure (BP) is lowered is
13 times greater than in the USA [8]. However, where
health-care provision is poor, detection and management
of hypertension can only be haphazard and unreliable.
Population-wide strategies to reduce BP could have an
important impact on the number of strokes in the com-
munity. Whilst there is some data from Ghana using hos-
pital series that stroke rates are increasing [9-11], one of
the general problems in sub-Saharan Africa is the lack of
reliable population-based morbidity and mortality data
on stroke and other chronic diseases. Death certification
and causes of death are not consistently recorded and
cause-specific mortality rates are derived through verbal
autopsies. Recent data from Tanzania [12] and South
Africa [13] suggest a high burden of stroke, comparable to
those seen in developed countries.
The World Health Organization regards population-wide
strategies as an integral part of the overall approach to the
prevention of cardiovascular disease worldwide, espe-
cially those that include dietary modification [14,15].
There is good evidence that a reduction in salt intake
reduces BP [16] and that people of black African origin liv-
ing in Africa respond well [17-19]. In the western world,
it is very difficult to implement successful salt reduction
strategies in the population since most of the salt ingested
is in processed food. So, any intervention would involve
the participation of the food industry and some attempts
have been made in Portugal [20] and Finland [21]. In con-
trast, in populations whose intake of processed food is
negligible – such as are found in many areas of sub-Saha-
ran Africa – salt reduction strategies should be relatively
easy to implement and have a good chance of success. To
date, however, there have been no such community inter-
vention studies in sub-Saharan Africa so the feasibility
and effectiveness of a health education approach to BP
reduction is unknown.
We started a programme with a view to establishing the
feasibility of salt reduction as a way of reducing BP in
twelve rural and semi-urban villages in the Ashanti region
of Ghana where we suspect that hypertensive-related vas-
cular diseases (namely stroke, renal and heart failure)
account for a significant proportion of morbidity and
mortality [22]. We conducted a pilot study, a household
survey and population census, a survey of risk factors, sub-
sequently randomised villages into clusters to receive gen-
eral health education or more specific education as to how
to reduce salt intake, then followed up the participants for
six months to evaluate the effect on sodium excretion and
BP. This paper describes the whole programme, highlights
the strengths and limitations of our approach as well as
the lessons learnt from our work, and suggests an interpre-
tation in the context of the low-resource countries of sub-
Saharan Africa.
Methods
Ethics
The study protocol was approved by the Committee on
Human Research Publication and Ethics of the School of
Medical Sciences, Kwame Nkrumah University of Science
and Technology, Kumasi and endorsed by the St George's
Healthcare NHS Trust Local Ethics Committee. As the
study got under way meetings were held with the Chief
and the Council of Elders in each village to explain the
study and to seek their permission for the study to take
place in their village.
Study area and population
The study was undertaken in the Ashanti region of central
Ghana where the Disability Adjusted Life Expectancy
(DALE) is 45.5 years [23]. Our study encompasses 12
communities in the Ejisu-Juabeng and Kumasi Districts
[24]. The villages were chosen in consultation with local
health workers [24]. The villages had little day-to-day con-
tact and direct communication with each other [24], and
transport between the villages is not generally available.
Six villages were considered to be rural as they lack elec-
tricity and piped water, have a small population and are
some distance from Kumasi [24,25]. The main occupation
is farming. The remaining six villages were considered
semi-urban. They are closer to Kumasi and usually have
electricity and piped water [24,25]. Although the main
activity is farming, trading is a frequent occupation. The
Komfo Anokye Teaching Hospital, the only Tertiary Refer-
ral Hospital in the region, serves the area. In 1995 the hos-
pital set up a BP clinic that now sees around 500 new
patients a year [22].
Household survey and population census
Following agreement with the Chiefs and Elders in each
village, a team of fieldworkers, fluent in both English and
Twi (the local language), carried out a population census
between January and March 2001 in order to create age-
and-sex registers for the villages [24]. A total of 16,965
individuals (6,597 rural and 10,368 semi-urban) from
1,460 households (750 rural and 710 semi-urban) werePage 2 of 11
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ages) of 1,414 inhabitants (range 562–1,966) [24]. The
adult population (>16 years) was 50% in rural and 57%
in semi-urban villages. The population structure of these
villages was comparable to that reported for Ghana as a
whole. There were 2,743 adults aged 40–75 years.
Recruitment of participants
Between 95 and 250 subjects aged 40 to 75 from each vil-
lage, total 1,896, were selected by stratified random sam-
pling by age and sex from the census of all inhabitants in
the village so that the total sample selected matched the
overall population structure. Between June 2001 and June
2002 a multidisciplinary study team set up a data collec-
tion centre in each village. All members of the team had
been trained to take measurements and to carry out pro-
cedures while adhering to a protocol. The information
sheet and consent form (available in both English and
Twi) was explained to each participant who, if agreeing to
take part, gave consent either by signing their name or
applying a thumbprint.
Baseline assessment
For each consenting participant a fieldworker completed a
detailed questionnaire, and measured height, weight and
BP. Where necessary the questioning was in Twi after local
Flow chart of the trialigure 1
Flow chart of the trial.
12 villages randomised
2743 eligible subjects
Intervention
6 villages
970 subjects randomly selected and 
invited to take part
Control
6 villages
920 subjects randomly selected and 
invited to take part
Intervention
6 villages
522 attended baseline assessment
Control
6 villages
491 attended baseline assessment
Villages randomised after baseline assessment
Intervention carried out
Intervention
6 villages
444 attended 3 month assessment
399 attended 6 month assessment
Control
6 villages
450 attended 3 month assessment
402 attended 6 month assessmentPage 3 of 11
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Socio-economic, lifestyle and medical information was
collected. Information was also gathered on five salty
foods – koobi, momoni, kako (all salted fish), salted pigs'
feet and salted beef [25]. The respondents were asked if
they ate these foods regularly and whether they added salt
at the table or during cooking.
Height and weight were measured and body mass index
(BMI) calculated [6]. BP and pulse rate were measured,
and participants were also asked whether they were on
regular anti-hypertensive drug therapy [6]. Venous blood
was collected using vacutainers. Samples were transported
to Komfo Anokye Teaching Hospital for aliquoting and
storage [6]. Two consecutive timed 24-hour urine samples
were obtained from each participant under close supervi-
sion. The urine samples were transported the same day to
Komfo Anokye Teaching Hospital. Aliquots were pre-
pared and frozen at -20°C. Serum and urine were later
shipped to London on dry ice for long-term storage.
Randomisation and power calculations
After recruitment of participants, villages were allocated to
intervention and control groups (Figure 1). Villages were
randomised in blocks of two, and stratified for locality
(semi-urban or rural) by an independent statistician [26].
Thus, intervention could begin in the first two villages
while subjects in the second two were being recruited. The
main outcomes of the trial were change in 24 h urinary
sodium over the follow-up period and change in systolic
BP. An average of 70 participants completing the trial
from each village would allow a change in systolic BP of
4.8 mmHg to be detected with 90% power, using a 5% sig-
nificance level, assuming the standard deviation of the
change in BP to be 12.6 mmHg and the intra cluster cor-
relation coefficient to be 0.02 [26]. Initially, 95 subjects
were invited from each village to allow for a 25% refusal
and attrition rate. As the response rate in the first four vil-
lages was lower than anticipated, more subjects were
recruited in the remaining villages to obtain sufficient
subjects overall and to allow for a greater refusal rate. The
groups were comparable for baseline characteristics
(Table 1).
Intervention programme
An intensive health education programme was carried out
by community health workers. The educational and
health promotion sessions were open to all villagers, irre-
spective of their participation into the trial. They were
encouraged to attend by preliminary meetings with health
visitors, the endorsement of their chief and community
leaders. The meetings were held daily for the first week of
the study and once weekly thereafter. The sessions were
held in communal areas like churches, churchyards,
schools, community centres. The sessions lasted approxi-
mately one hour (both for intervention and control). We
did not record the actual number of attendants at each
meeting as they were in relatively large numbers and,
therefore, we are unable to report response rates at each
session. The spirit of the intervention was to expose the
whole community to the health promotion message and
to test only a random proportion of them. A standard
health education package from the Ghana Ministry of
Health was used in all the villages. Flip charts were the
main medium of communication; they consisted of dou-
ble-sided A3-sized sheets with a colour picture on one side
(shown to the participants) and written text on the other
(facing the health visitor and used as a prompt). The pub-
lic health issues included prevention of malaria, infective
diarrhoeas and roundworm infection, as well as enhanc-
ing awareness of diabetes and high blood pressure. No
mention was made of any possible dietary prevention of
hypertension. In the intervention villages additional
advice was given not to add salt to food and in cooking, to
limit the amount of koobi, momoni, kako and tilapia
(salted fish), salted pigs' feet and salted beef and to soak
the items in water overnight before eating them. In order
to avoid potential bias and contamination, we sought to
maintain 'blindness' of the participants as to which die-
tary intervention they were receiving. On the other hand,
we could not keep the community health nursing staff
blind to the main objectives of the study. The feasibility of
this approach had been tested in a small pilot study
reported elsewhere [17].
Participants randomised to take part into the trial (both
intervention and control) were given a small gift at the
Table 1: Regression coefficients (and 95% C.I.) for blood pressure¶ over sodium excretion adjusted for age, sex, locality, body mass 
index (random effect model)
Unit change Systolic B.P. (mmHg) Diastolic B.P. (mmHg)
50 mmol of 24 h urinary sodium 2.17 (0.44 to 3.91)# 1.01 (0.08 to 1.94)#
Unit of sodium: creatinine ratio 0.45 (0.17 to 0.75)# 0.18 (0.02 to 0.33)#
Unit of sodium: potassium ratio 1.74 (0.45 to 3.03)# 1.16 (0.43 to 1.80)#
¶ Adjusted for time of day. # p < 0.001Page 4 of 11
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mackerel, paracetamol, folic acid and some vitamin sup-
plements; however they did not know this prior to partic-
ipating, so that the response rate is likely to represent an
unbiased response to a health promotion initiative. Like-
wise, the whole village was presented with a gift at the end
of the study consisting of either a television set for the
communal room (where there was electricity) or corru-
gated roofing sheets as a contribution to the building of
local schools or community areas.
Follow-up
Participants were re-examined at 3 months and 6 months.
At the 3-month visit a history of drug therapy was taken,
and weight, BP and pulse were measured and recorded.
Two 24-hour urine samples were collected but blood sam-
ples were not taken. At 6 months the same measurements
were made, and on this occasion a blood sample as well.
These urine and blood samples were processed in a simi-
lar way to the baseline samples. At 3 months 894 subjects
attended and 889 (558 women and 331 men) were
included in the analysis of urinary sodium. Of these 833
(531 women and 331 men) were based on two samples
and 56 on one sample because a blinded assessment of
the data indicated that one sample was incomplete or
over-collected; 9% of men and 5% of women had only
one sample. At 6 months 801 subjects attended and 800
(493 women and 307 men) were included in the analysis
of urinary sodium. Of these 754 (465 women and 289
men) were based on two samples and 46 on one sample;
4% of men and 6% of women had only one sample. The
overall response rate at baseline was 53% (1,013/1,896)
but this varied considerably between villages (range 40%
to 88%). Response rates were higher in women than men;
58% (628/1,088) v 48% (385/808) and responders were
2.0 (95% CI: 0.8 to 3.1) years older than non responders.
In rural villages men and women responded similarly
(57% v 60%; difference -3% [-21 to 20%]) but in the
semi-urban villages men were less likely to respond (41%
v 56%; difference -15% [26 to -4%]). Follow-up rate at 6
months was similar in men and women (307/385 or 80%
vs 494/628 or 79%). Attenders were 2.5 (0.8 to 4.2) years
older than those who dropped out. Follow-up rates varied
between villages from 62% to 92%.
Statistical analysis
Regression analysis with robust standard errors was used
to assess the effects of time of day on BP and pulse rate
using the baseline measurements, adjusting for age, sex,
locality, BMI and interaction between age and sex. All BP
and pulse rate measurements were adjusted using these
models prior to further analysis. The relationship between
BP and sodium excretion, and between change in BP and
change in sodium excretion were estimated using a ran-
dom effects regression model with maximum likelihood
estimation to allow for clustering within villages. The
intervention effect was estimated as the difference in the
change in the outcome in the intervention and control
groups so that a negative difference favours the interven-
tion. The analysis was carried out using a random effects
regression. Adjusted changes in urine sodium-to-creati-
nine ratio for each village were estimated from ordinary
least squares regression in each village and plotted using a
random effect meta-analysis procedure. The correlation
Table 2: Baseline characteristics of the population in the intervention and control groups.
Intervention (n = 522) Control (n = 491)
Age 54 (11) 55 (11)
Female n (%) 324 (62) 304 (62)
Height in cm 160 (8) 161 (8)
Weight in kg 54 (11) 54 (11)
Body mass index (kg/m2) 21 (4) 21 (4)
Systolic blood pressure (mmHg)¶ 129 (25) 127 (27)
Diastolic blood pressure (mm Hg)¶ 77 (13) 76 (13)
Heart rate (bpm)¶ 74 (12) 72 (12)
Urinary sodium (mmol/24 h) 99.9 (44.7) 102.5 (45.3)
Urinary potassium (mmol/24 h) 47.5 (23.2) 49.3 (23.6)
Urinary creatinine (mmol/24 h) 8.4 (2.6) 8.4 (2.6)
Urinary sodium/potassium ratio 2.4 (1.2) 2.4 (1.3)
Urinary sodium/creatinine ratio 12.4 (5.3) 12.7 (5.6)
Urinary potassium/creatinine ratio 5.9 (2.8) 6.1 (2.8)
Current smoking n (%) 31 (6) 41 (8)
Alcohol drinking n (%) 199 (38) 211 (43)
Hypertensive n (%) 154 (30) 137 (28)
2 subjects have missing urine collections at baseline
¶ Adjusted for time of day
Results are means (standard deviations) or number (percentage)Page 5 of 11
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subjects was calculated using the meta-regression proce-
dure. All analyses were carried out using Stata version 7.0.
Results
General characteristics
There were 1,013 participants in the study (385 men and
628 women); of these 532 were from semi-urban and 481
from rural villages. Ninety per cent of them reported being
aged 40 to 75 years (mean age 54.7 years [SD 11.3]). Salt
was almost invariably added to food in cooking (98%)
and salted foods such as fish and meat were eaten in both
rural and semi-urban villages. Salt was often added at the
table (52%), more often in rural villages than in semi-
urban settings (59 v 45%; p < 0.01), although the total salt
consumed as measured by urinary sodium was similar (99
v 103 mmol/day). Urinary potassium levels were higher
in rural villages (58 v 40 mmol/day; difference 18 mmol/
day [11 to 26]; p < 0.001). In semi-urban villages people
were heavier (BMI 22.3 [4.6] vs 19.8 [3.2] kg/m2, p <
0.001) and had higher BP (129/76 [26/14] vs 121/72 [25/
13] mmHg, p < 0.001 for both systolic and diastolic BP).
The prevalence of hypertension increased with age and
was more common in semi-urban settings [6].
Effect of time of day
There was a significant difference in the time of the day at
which BP and pulse rate were taken at baseline (mean
time of the day 9.28 [SD 1.39] equivalent to 9:17 am)
compared with the two follow-up periods (7.57 [0.77]
equivalent to 7:34 am at 3 months and 7.67 [0.73] equiv-
alent to 7:40 am at 6 months), due to the necessity for tak-
ing much larger numbers of measurements at baseline.
This difference in time of day of screening was associated
with a significant drift in both BP and pulse rate. At base-
line, there was a 1.90 mmHg [95% CI 0.63 to 3.24; p <
0.001) lower systolic and a 1.45 mmHg [0.66 to 2.20; p <
0.001) lower diastolic BP for every hour of time of day of
screening with a higher pulse rate of 0.85 bpm per hour
(0.14 to 1.56; p < 0.001). These estimates are compatible
with those reported in earlier studies both in whites [27]
and black Africans [28]. Further analyses are therefore
reported with BP and pulse rate adjusted for time of day
and standardised to 8:00 am.
Relationship between urinary sodium and BP
There was a significant and positive relationship between
the level of salt intake (however estimated) and both
systolic and diastolic BP (Table 1). When allowing for the
potential confounding effects of age, gender, locality, BMI
and clustering, there was a 2.2 mmHg lower systolic and a
1.0 mmHg lower diastolic BP for a 50 mmol/day lower
urinary sodium excretion. These relationships were signif-
Changes in sodium-to-creatinine ratio adjusted for age, sex, BMI at baseline and l cality by number of subjects recruitedfrom each villageFigur  3
Changes in sodium-to-creatinine ratio adjusted for 
age, sex, BMI at baseline and locality by number of 
subjects recruited from each village. Regression coeffi-
cient = -0.03 [-0.05 to 0], p = 0.042 from meta-regression 
analysis.
Changes in sodium-to-creatinine ratio adjusted for age, sex, BMI at baseline and l cality (rural or semi-urban) in each vil-lage for th  tervention and control groups of villag sFigur 2
Changes in sodium-to-creatinine ratio adjusted for age, sex, 
BMI at baseline and locality (rural or semi-urban) in each vil-
lage for the intervention and control groups of villages.Page 6 of 11
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and sodium-to-potassium ratio (Table 1).
Effect of the intervention programme on salt intake
The intervention and control groups were comparable for
baseline characteristics (Table 2). In the intervention
group 47% were from rural villages compared to 53% in
the control group. During the health promotion pro-
gramme the change in average sodium excretion varied
between villages. It fell in four out of six villages in the
intervention group and in 5 out of six villages in the con-
trol group (Figure 2). The net intervention effect was
therefore a non-significant change in sodium excretion
(Table 3 and 4). Smaller villages (with smaller samples)
showed a greater reduction in urinary sodium excretion
than larger villages (with larger samples) (p = 0.042) (Fig-
ure 3).
Effect of the intervention programme on BP
Intention-to-treat analysis
Throughout the trial we observed that the intervention
group showed a small reduction in both systolic and
diastolic BP, more pronounced at 6 months and statisti-
cally significant for diastolic BP at 6 months (Table 3 and
4). This effect was not consistent with the effect observed
on urinary sodium excretion (Table 3 and 4).
On-diet analysis
At both 3 and 6 months, there was a consistent and signif-
icant relationship between the fall in urinary sodium
excretion (however expressed) and the fall in systolic BP,
when adjusting for confounders (Table 5). A 50 mmol per
day lower urinary sodium was associated with a fall in
systolic BP between 1.0 and 3.2 mmHg at 3 months and
0.1 to 2.6 mmHg at 6 months. The effect on diastolic BP
was less consistent, although in the same direction.
Discussion
This is the first attempt of a community-based trial of
health promotion in rural and semi-urban villages in sub-
Saharan Africa to achieve a population-wide reduction in
salt intake with a view to reducing the population BP. The
programme was complex and beset by practical difficul-
ties. It has nevertheless produced important findings.
We have arrived at estimates of BP and salt intake in the
Ashanti region of Ghana, and have gathered data on the
efficacy and potential effectiveness of a programme of a
Table 3: Baseline and (a) three months values or (b) six months values for blood pressure¶ and sodium and potassium excretion for all 
participants followed-up to that time point.
(a) Baseline Three months
Intervention (n = 444) Control (n = 450) Intervention (n = 444) Control (n = 450)
Systolic blood pressure (mm Hg) 128.5 (24.7) 127.3 (26.3) 124.6 (26.6) 123.8 (26.0)
Diastolic blood pressure (mm Hg) 76.8 (13.0) 75.8 (13.5) 74.2 (13.7) 74.0 (14.1)
Urinary sodium (mm/24 h) 100.9 (44.3) 103.6 (45.3) 94.0 (44.5) 97.5 (42.3)
Urinary potassium (mm/24 h) 48.3 (23.5) 49.3 (23.4) 50.1 (20.8) 52.1 (23.6)
Urinary creatinine (mm/24 h) 8.4 (2.6) 8.4 (2.6) 7.8 (2.5) 7.9 (2.8)
Urinary sodium/potassium ratio 2.4 (1.2) 2.4 (1.3) 2.1 (1.1) 2.1 (1.1)
Urinary sodium/creatinine ratio 12.4 (5.2) 12.8 (5.6) 12.4 (5.4) 13.0 (5.6)
Urinary potassium/creatinine ratio 6.0 (2.8) 6.1 (2.8) 6.7 (2.9) 6.9 (2.9)
(b) Baseline Six months
Intervention (n = 399) Control (n = 402) Intervention (n = 399) Control (n = 402)
Systolic blood pressure (mm Hg) 129.2 (24.6) 125.6 (25.5) 127.9 (27.7) 127.4 (26.0)
Diastolic blood pressure (mm Hg) 76.9 (13.0) 75.2 (13.3) 76.0 (14.2) 78.7 (14.3)
Urinary sodium (mm/24 h) 100.7 (45.2) 104.2 (45.5) 91.8 (41.8) 89.8 (39.1)
Urinary potassium (mm/24 h) 48.5 (23.9) 50.9 (24.2) 48.2 (21.5) 52.1 (21.9)
Urinary creatinine (mm/24 h) 8.4 (2.6) 8.4 (2.5) 8.0 (2.6) 8.0 (2.5)
Urinary sodium/potassium ratio 2.4 (1.3) 2.4 (1.3) 2.2 (1.2) 1.9 (1.0)
Urinary sodium/creatinine ratio 12.4 (5.2) 12.8 (5.6) 11.9 (5.1) 11.7 (4.7)
Urinary potassium/creatinine ratio 6.0 (2.9) 6.3 (2.9) 6.3 (2.7) 6.8 (2.7)
¶ Adjusted for time of day
Missing values for urinary variables; intervention, 3 months n = 1, control, baseline n = 1, 3 months n = 4
Missing values for urinary variables; control, baseline n = 1, 6 months n = 1Page 7 of 11
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can villagers. We chose the most difficult setting to imple-
ment a population-wide strategy, i.e. rural communities
where the people are predominantly non-hypertensive
and whose salt intake is lower than that found in most
western countries.
Strengths and limitations of our study
To avoid potential confounding due to the localities we
undertook stratification at cluster level. We also stratified
at individual level in order to achieve the same age-gender
structure of the invited sample of each village. Recruit-
ment was carried out blind to avoid possible recruitment
bias if the response rate proved to be low – as it was in
some villages. The response rate was lower than expected
for reasons unrelated to the intervention itself. There was
a delay of up to 18 months between the household survey
and starting the fieldwork in some villages. Villagers had
sometimes forgotten that they had agreed to take part in
the study and others had died or moved out of the area.
Blood sampling was also sometimes a cause of difficulty.
Blood was taken to measure factors related to cardiovascu-
lar disease but in some villages rumours spread that the
blood was to be tested for HIV infection; in Ghana as in
other parts of the world a positive HIV test carries a stigma
for the whole family. Another rumour was that the blood
would be sold in London. The timing of the blood sample
required thought. While the time of data collection (6 am
onwards) suited those working on their farms locally, as
well as those remaining in the village, it did not suit those
who left for work much earlier. This phenomenon proba-
bly accounted for the lower response rate amongst men in
semi-urban villages.
Interpretation of our study
Despite our careful planning, we did not manage to com-
plete a fully randomised trial due to the contamination of
the two intervention arms. Initially, we found the inter-
vention effects difficult to interpret since the changes in
BP and sodium excretion within each village were less
than expected from the pilot study [17]. Possible explana-
tions included contamination due to two reasons. First,
the participants of intervention and control villages could
have had contact with each other and exchanged informa-
tion about the content of the health promotion. This was
unlikely as the villages had been selected because not only
were they several kilometres away from each other but
also used different markets, and had no easy means of
communication [24]. Alternatively, contamination could
have arisen through the health workers who, despite their
training and awareness of the purpose and scope of the
study and the importance of concealing the true objec-
tives, did unwittingly give information on salt reduction
to villagers in the control villages in the belief that they
should attempt to improve the health of all the villagers.
Finally, a true variation in response between villages can-
not be excluded. The disappointing outcomes could have
been related to differing attitudes of different fieldwork-
ers, variable co-operation of villagers (some villages were
united, some less so), proportion of villagers in the village
at the time of the educational sessions, and clashes with
other events related to farming.
Table 4: Effect of intervention (and 95% CI) on reduction in blood pressure¶ and urinary sodium excretion at 3 and 6 months adjusted 
for age, sex, locality, body mass index (random effect model)
Variable 3 months (n = 894) 6 months (n = 801)
SBP (mmHg) -0.48 (-5.45 to 4.50) -2.54 (-6.54 to 1.45)
DBP (mmHg) -1.02 (-3.95 to 1.91) -3.95 (-7.11 to -0.78)**
Urinary sodium (mmol/24 h) -0.5 (-12.3 to 11.3) 6.0 (-4.1 to 16.1)
Urinary sodium: creatinine -0.01 (-1.35 to 1.32) 0.85 (-0.53 to 2.24)
Urinary sodium: potassium 0.08 (-0.22 to 0.39) 0.30 (0.02 to 0.57)*
¶ Adjusted for time of day *p = 0.03, **p = 0.015
Effect is control – intervention (negative values favour intervention).
Table 5: Regression coefficients (and 95% C.I.) for changes in blood pressure¶ for a given change in sodium excretion adjusted for age, 
sex, locality, body mass index (random effect model)
Unit change Month Systolic B.P. (mmHg) Diastolic B.P. (mmHg)
50 mmol of 24 h urinary sodium 3 2.12 (1.03 to 3.21)# 1.11 (0.45 to 1.78)#
6 1.34 (0.08 to 2.60)* 0.30 (-0.45 to 1.04)
Unit of sodium: creatinine ratio 3 0.33 (0.15 to 0.51)# 0.14 (0.03 to 0.25)**
6 0.30 (0.08 to 0.53)§ 0.03 (-0.10 to 0.17)
Unit of sodium: potassium ratio 3 1.59 (0.73 to 2.46)# 0.48 (-0.05 to 1.00)
6 1.94 (0.97 to 2.90)# 0.47 (-0.11 to 1.04)
¶ Adjusted for time of day #p < 0.001; §p = 0.008; **p = 0.015; *p = 0.037Page 8 of 11
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lages in the control group receiving advice on salt reduc-
tion, the regression analysis could provide an estimate of
effect on BP of a reduction in urinary sodium excretion in
all villages, irrespective of treatment allocation. We would
then expect a greater reduction in BP for a greater reduc-
tion in urinary sodium. This is what we found, and it sup-
ports our concept. It can be argued, however, that this
association can be merely due to some changes over time
having an effect on both sodium and blood pressure. We
cannot rule this out. We do not think our findings are
explained by chance, though.
When measuring BP, the possibility of confounding fac-
tors at village level cannot be ruled out, and we have
shown, for example, that time of day is a significant pre-
dictor of BP. Since we have no records of ambient temper-
ature, we have had to use time of day instead. The
difference in BP predicted by a 2 h difference in the time
of day is of the same order of magnitude of that expected
by the intervention. Since all measurements were taken on
the same day in each village, the BP measurements are
also highly clustered. This means that in some villages,
because of the effect of temperature, the BP may have
risen even though sodium excretion may have fallen.
Our data in the context of Africa
Two intervention trials of dietary salt reduction in popu-
lations of African origin have been published so far
[18,19]. Both were carried out in clinical settings under
controlled experimental conditions and lasted 3-weeks.
The authors suggest that the efficacy of a reduction in salt
intake in developing countries equals that noted in more
affluent cultures and in whites [16,29]. Our study extends
these observations for the first time to a community set-
ting and on a longer term to provide some evidence of
effectiveness. As expected, the longer the study – in our
case health promotion – the less pronounced the efficacy,
presumably as a result of adaptation and reduced compli-
ance as has been shown in studies in the Western world
dealing with salt intake [30] and weight reduction [31].
Some have argued that health promotion programmes of
cardiovascular prevention in the Western world should
not be exported to developing countries because such pro-
grammes would be difficult to implement [32,33]. They
have suggested that 'counting deaths' – a relatively easy task
that focuses on 'surveillance' of cardiovascular disease in
Africa – would lead to more effective prevention [32]. At
the same time, they recognise that 'it is essential that con-
text-appropriate health research and health interventions take
place in developing countries' [33].
It would be simplistic to pre-judge the outcome of con-
text-specific health promotion strategies based on experi-
ences of the western world. Cultural and behavioural
factors are often responsible for successes or failures of
community interventions and it is likely that different
mechanisms would operate in different contexts, so
defeating mere generalisations. Furthermore, educational
interventions in whole communities are 'complex inter-
ventions' that often pose significant problems of evalua-
tion due to the difficulty of standardising their
components [34].
Within the context of low-income countries in epidemio-
logical transition, the case in favour of a population-based
approach to limiting the rise in BP and ensuing stroke and
renal risk is compelling [35,36]. In Ghana, structures for
the detection, management and control of high BP out-
side cities and large towns are virtually absent [6]. Anti-
hypertensive drugs are not free and most people in need
cannot afford them [37]. It has been argued that drug
treatment of cardiovascular risk factors in African commu-
nities will divert the already scarce resources away from
needier areas of healthcare, such as maternal and child
health, diarrhoeal diseases and malaria. The advent of free
anti-retroviral therapy in many areas of sub-Saharan
Africa will necessarily lead to the development of systems
for the provision of drugs for the management of other
chronic diseases. However, such advances are unlikely for
many years, and the cheaper option of encouraging life-
style changes is likely to be the preferred policy for some
time.
Perspectives
In the DASH-Sodium study a reduction from 6.3 to 3.9 g
of salt per day (~38 mmol of sodium per day) in non-
hypertensive people caused a reduction in BP of 3.4/2.0
mmHg [38]. The effect was much greater in hypertensives,
in African Americans and more pronounced the greater
the change in salt intake [16,38]. By using the combined
evidence from trials in the literature a modest reduction in
salt intake of ~3 g per day (50 mmol of sodium) in non-
hypertensive people would reduce BP by 2 to 4/1 to 2
mmHg [39]. This reduction, if sustained long-term, would
be responsible for a reduction in stroke events of 12–14%
per year [29,39]. The efficacy of salt reduction in lowering
BP levels has been confirmed recently in two small short-
term clinical trials in Nigeria [18] and Jamaica [19].
How far would a reduction of 1.3 mmHg in population
systolic BP – as shown in our study – impact on stroke
rates? No randomised clinical trials have been performed
to show that a sustained reduction in salt intake leads to a
reduction of cardiovascular events; however, evidence
from prospective studies suggests that those eating less
salt have a reduced risk of cardiovascular events [21,40-
42]. From prospective studies, randomised clinical trials
of BP lowering treatment with drugs and short term trialsPage 9 of 11
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by at least 10% in non-hypertensive individuals whose
salt intake was reduced by 50 mmol per day and systolic
BP by 1.3 mmHg [39]. In hypertensive individuals the
benefit would be much greater. There is no evidence so far
to guide us to extrapolate these benefits to African popu-
lations. It can be argued, however, that the attributable
preventive fraction could be greater, given less competing
cardiovascular risk in these populations.
Finally, our study design aimed specifically at changing
salt intake, without targeting other aspects of the partici-
pants' diet. It is conceivable that a combined approach
with an increase in potassium intake (not as high in this
population as one would have expected) alongside a
modification of their fat intake (mainly coming from the
use of palm and coconut oils rather than dairy products)
might exert compounding effects on lowering of blood
pressure and prevention of strokes.
Conclusion
The impending epidemic of cardiovascular disease in sub-
Saharan Africa in a context of lack of resources is a serious
global public health challenge. Community-based strate-
gies of health promotion for the management of chronic
disease through lifestyle change in sub-Saharan Africa
should be considered.
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